rewirebio.iobenchmarks
Source

Automated reanalysis of genomic data for rare disease diagnostics at scale

Nature Medicine 2026 final publication, 24 June 2026 · Peer-reviewed

DOI: 10.1038/s41591-026-04477-5Original source

What this source contributed

Records in this release that cite this source. A record can cite several sources.

Results

Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.

Model or configurationMetricValueDatasetEvaluation
Exomiser v14 default, Talos 2026 comparisonCount (rank: any)172 countACG trios: Exomiser SNV/indel comparison as reported in ResultsExomiser v14 ACG trio rank-budget evaluation
Exomiser v14 default, Talos 2026 comparisonCount (rank: top 1)127 countACG trios: Exomiser SNV/indel comparison as reported in ResultsExomiser v14 ACG trio rank-budget evaluation
Exomiser v14 default, Talos 2026 comparisonCount (rank: top 5)157 countACG trios: Exomiser SNV/indel comparison as reported in ResultsExomiser v14 ACG trio rank-budget evaluation
Exomiser v14 default, Talos 2026 comparisonCount (rank: top 10)164 countACG trios: Exomiser SNV/indel comparison as reported in ResultsExomiser v14 ACG trio rank-budget evaluation
Exomiser v14 default, Talos 2026 comparisonRecall (rank: any)89% percentACG trios: Exomiser SNV/indel comparison as reported in ResultsExomiser v14 ACG trio rank-budget evaluation
Exomiser v14 default, Talos 2026 comparisonTop-1 accuracy65% percentACG trios: Exomiser SNV/indel comparison as reported in ResultsExomiser v14 ACG trio rank-budget evaluation
Exomiser v14 default, Talos 2026 comparisonTop-5 accuracy81% percentACG trios: Exomiser SNV/indel comparison as reported in ResultsExomiser v14 ACG trio rank-budget evaluation
Exomiser v14 default, Talos 2026 comparisonTop-10 accuracy85% percentACG trios: Exomiser SNV/indel comparison as reported in ResultsExomiser v14 ACG trio rank-budget evaluation
Talos monthly iterative reanalysis with clinical confirmationCount (diagnoses: first cycle)221 countTalos 4,735 unresolved individualsTalos monthly reanalysis programme
Talos monthly iterative reanalysis with clinical confirmationCount (diagnoses: improved analysis)109 countTalos 4,735 unresolved individualsTalos monthly reanalysis programme
Talos monthly iterative reanalysis with clinical confirmationCount (diagnoses: later cycles)20 countTalos 4,735 unresolved individualsTalos monthly reanalysis programme
Talos monthly iterative reanalysis with clinical confirmationCount (diagnoses: new confirmed)241 countTalos 4,735 unresolved individualsTalos monthly reanalysis programme
Talos monthly iterative reanalysis with clinical confirmationCount (diagnoses: new gene-disease evidence)78 countTalos 4,735 unresolved individualsTalos monthly reanalysis programme
Talos monthly iterative reanalysis with clinical confirmationCount (diagnoses: new variant evidence)54 countTalos 4,735 unresolved individualsTalos monthly reanalysis programme
Talos monthly iterative reanalysis with clinical confirmationCount (newly diagnosed individuals)238 countTalos 4,735 unresolved individualsTalos monthly reanalysis programme
Talos monthly iterative reanalysis with clinical confirmationDiagnostic yield (additional yield from reanalysis)5.1% percentTalos 4,735 unresolved individualsTalos monthly reanalysis programme
Talos monthly iterative reanalysis with clinical confirmationNew candidates per 1000 cases per cycle5 variants-per-1000-cases-per-cycleTalos 4,735 unresolved individualsTalos monthly reanalysis programme
Talos monthly iterative reanalysis with clinical confirmationProportion (diagnoses: first cycle)92% percentTalos 4,735 unresolved individualsTalos monthly reanalysis programme
Talos monthly iterative reanalysis with clinical confirmationProportion (diagnoses: improved analysis)45% percentTalos 4,735 unresolved individualsTalos monthly reanalysis programme
Talos monthly iterative reanalysis with clinical confirmationProportion (diagnoses: later cycles)8% percentTalos 4,735 unresolved individualsTalos monthly reanalysis programme
Talos monthly iterative reanalysis with clinical confirmationProportion (diagnoses: new gene-disease evidence)32% percentTalos 4,735 unresolved individualsTalos monthly reanalysis programme
Talos monthly iterative reanalysis with clinical confirmationProportion (diagnoses: new variant evidence)22% percentTalos 4,735 unresolved individualsTalos monthly reanalysis programme

Claims

Statements this source supports, each with where in the source it was checked.

Models, benchmarks and other records

Methods (2)

Configurations (6)

Benchmarks (1)

Protocols (2)

Datasets (2)

Baselines (3)

Evaluations (2)

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

16 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Artifact retrieved at
2026-09-30T21:24:16Z
Source metadata
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_retrieved_at

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Artifact SHA-256
629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec
Source metadata
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_sha256

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Artifact url
https://www.nature.com/articles/s41591-026-04477-5
Source metadata
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_url

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Doi
10.1038/s41591-026-04477-5
Source metadata
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.doi

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Publication status
peer_reviewed
Source metadata
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.publication_status

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Retrieved at
2026-09-30T21:43:37Z
Source metadata
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.retrieved_at

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Url
https://www.nature.com/articles/s41591-026-04477-5
Source metadata
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.url

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Version
Nature Medicine 2026 final publication, 24 June 2026
Source metadata
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Description
Primary source inspected for the scoped extraction; automated review does not establish replication.
Source metadata
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

catalogued

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Facets: areas
1 values
  • dna-genomes
Source metadata
Automated reanalysis of genomic data for rare disease diagnostics at scale

Original source ↗

No field-specific location recorded

Version: Nature Medicine 2026 final publication, 24 June 2026
Retrieved: 2026-09-30T21:24:16Z

catalogued

No individual claim review recorded

Audit details

Field: facets.areas

Source artifact SHA-256: 629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

Primary source inspected for the scoped extraction; automated review does not establish replication.

Release history

No supporting source is linked yet.

Read original source

Download this release (gzip)
Technical metadata and extraction receipts

Stable ID: uc-clinical-20260930-source-talos

areas
dna-genomes
contexts
clinical_research
url
https://www.nature.com/articles/s41591-026-04477-5
retrieved at
2026-09-30T21:43:37Z
version
Nature Medicine 2026 final publication, 24 June 2026
publication status
peer_reviewed
doi
10.1038/s41591-026-04477-5
artifact sha256
629b9578ac42717245256feca69dc9c9d5442deb7d282dd1bdc5a6c1a1efd2ec
artifact url
https://www.nature.com/articles/s41591-026-04477-5
artifact retrieved at
2026-09-30T21:24:16Z
Related records

    Suggest a correction